19-Apr-2024
Analysts Are Bullish on Top Healthcare Stocks: Thermo Fisher (TMO), Intra-Cellular Therapies (ITCI)
TipRanks (Thu, 18-Apr 9:50 PM ET)
TipRanks (Thu, 18-Apr 8:20 AM ET)
Intra-Cellular Therapies drops 2%, prices $500M equity financing
Seeking Alpha News (Thu, 18-Apr 2:47 AM ET)
Intra-Cellular Therapies Prices Public Offering of Common Stock
Globe Newswire (Wed, 17-Apr 8:46 PM ET)
TipRanks (Wed, 17-Apr 5:20 AM ET)
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
Benzinga (Wed, 17-Apr 2:06 AM ET)
ENPH, OCUL and ITCI are among after hour movers
Seeking Alpha News (Tue, 16-Apr 5:02 PM ET)
Intra-Cellular Therapies announces proposed public offering of common stock
Seeking Alpha News (Tue, 16-Apr 4:10 PM ET)
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Globe Newswire (Tue, 16-Apr 4:06 PM ET)
Intra-Cellular Therapies: Hold Rating with Increased Price Target Amid Caplyta’s Clinical Success
TipRanks (Tue, 16-Apr 3:45 PM ET)
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
Intra-Cellular Therapies trades on the NASDAQ stock market under the symbol ITCI.
As of April 19, 2024, ITCI stock price climbed to $72.37 with 1,847,691 million shares trading.
ITCI has a beta of 1.00, meaning it tends to be less sensitive to market movements. ITCI has a correlation of 0.13 to the broad based SPY ETF.
ITCI has a market cap of $7.05 billion. This is considered a Mid Cap stock.
Last quarter Intra-Cellular Therapies reported $132 million in Revenue and -$.30 earnings per share. This fell short of revenue expectation by $-5 million and exceeded earnings estimates by $.13.
In the last 3 years, ITCI stock traded as high as $84.89 and as low as $28.40.
The top ETF exchange traded funds that ITCI belongs to (by Net Assets): VTI, VB, IWM, VXF, VBK.
ITCI stock has underperformed the market in the last year with a return of +16.4%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ITCI shares. However, ITCI has outperformed the market in the last 3 month and 2 week periods, returning +10.6% and +5.7%, while SPY returned +3.0% and -4.5%, respectively. This indicates ITCI has been having a stronger performance recently.
ITCI support price is $70.14 and resistance is $73.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ITCI stock will trade within this expected range on the day.